{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:13:54Z","timestamp":1771046034033,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jcf.2023.08.012","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T21:39:39Z","timestamp":1694554779000},"page":"1120-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A pediatric cystic fibrosis arthropathy case who responded to Elexacaftor\/Tezacaftor\/Ivacaftor therapy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-9196","authenticated-orcid":false,"given":"Meliksah","family":"Arslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-4340","authenticated-orcid":false,"given":"Zeynep","family":"Bahadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-1037","authenticated-orcid":false,"given":"Matthew L.","family":"Basiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-9023","authenticated-orcid":false,"given":"Sarah J.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadir","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.08.012_bib0001","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jcf.2023.08.012_bib0002","first-page":"192","article-title":"The first triple-combination cystic fibrosis transmembrane conductance regulator modulating therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J Pediatr Pharmacol Ther JPPT Off J PPAG"},{"key":"10.1016\/j.jcf.2023.08.012_bib0003","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cell.2019.12.032","article-title":"A therapy for most with cystic fibrosis","volume":"180","author":"Bear","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jcf.2023.08.012_bib0004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3476(79)80018-9","article-title":"Episodic arthritis in children with cystic fibrosis","volume":"94","author":"Newman","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.08.012_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/ppul.24290","article-title":"Assessing arthritis in the context of cystic fibrosis","volume":"54","author":"Clarke","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.08.012_bib0006","article-title":"24.\u2003Chronic inflammatory arthritis in the context of cystic fibrosis","volume":"3","author":"Clarke","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jcf.2023.08.012_bib0007","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/31.8.535","article-title":"Cystic fibrosis arthritis. A report of five cases","volume":"31","author":"Pertuiset","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jcf.2023.08.012_bib0008","first-page":"651","article-title":"Episodic arthropathy in adult cystic fibrosis","volume":"64","author":"Bourke","year":"1987","journal-title":"QJM"},{"key":"10.1016\/j.jcf.2023.08.012_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpainsymman.2008.08.009","article-title":"Pain in children and adults with cystic fibrosis: a comparative study","volume":"38","author":"Sermet-Gaudelus","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jcf.2023.08.012_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0049-0172(86)90018-1","article-title":"The musculoskeletal manifestations of cystic fibrosis","volume":"15","author":"Rush","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcf.2023.08.012_bib0011","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.295.6600.699","article-title":"Arthropathy in a patient with cystic fibrosis taking ciprofloxacin","volume":"295","author":"Alfaham","year":"1987","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.jcf.2023.08.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006838.pub3","article-title":"Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis","volume":"2012","author":"Thornton","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.08.012_bib0013","article-title":"Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis","volume":"2016","author":"Thornton","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.08.012_bib0014","unstructured":"FDA Approves Trikafta for Children ages 6 through 11 with certain mutations | cystic fibrosis foundation 2021. https:\/\/www.cff.org\/news\/2021-06\/fda-approves-trikafta-children-ages-6-through-11-certain-mutations (accessed February 16, 2023)."},{"key":"10.1016\/j.jcf.2023.08.012_bib0015","first-page":"3","article-title":"CFTR modulator therapies \u2013 effect on life expectancy in people with cystic fibrosis","volume":"42","author":"Balfour-Lynn","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2023.08.012_bib0016","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.08.012_bib0017","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/jpm11080811","article-title":"Management of individual patient expectations when starting with highly effective CFTR modulators","volume":"11","author":"Aalbers","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2023.08.012_bib0018","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/jcm11041021","article-title":"Elexacaftor\/tezacaftor\/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation and advanced lung disease: a 48-week observational study","volume":"11","author":"Carnovale","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2023.08.012_bib0019","first-page":"e16144","article-title":"A review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy","volume":"13","author":"Zaher","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2023.08.012_bib0020","first-page":"e17229","article-title":"Chronic joint pain in a young adult with cystic fibrosis","volume":"13","author":"Prajapati","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2023.08.012_bib0021","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/jcm12051730","article-title":"Concomitant use of elexacaftor\/tezacaftor\/ivacaftor and etanercept in a cystic fibrosis patient with juvenile idiopathic arthritis","volume":"12","author":"Orsini","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2023.08.012_bib0022","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jcf.2015.12.022","article-title":"Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy","volume":"15","author":"Fitch","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.08.012_bib0023","doi-asserted-by":"crossref","first-page":"e49248","DOI":"10.7554\/eLife.49248","article-title":"ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis","volume":"8","author":"Scambler","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jcf.2023.08.012_bib0024","doi-asserted-by":"crossref","first-page":"e54556","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jcf.2023.08.012_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107437","article-title":"Regulatory T cell enhancement in adults with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"14","author":"Westh\u00f6lter","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2023.08.012_bib0026","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.202106-1426OC","article-title":"Trikafta rescues CFTR and lowers monocyte P2\u00d77R-induced inflammasome activation in cystic fibrosis","volume":"205","author":"Gabillard-Lefort","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.08.012_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02861-2021","article-title":"Cystic fibrosis macrophage function and clinical outcomes after elexacaftor\/tezacaftor\/ivacaftor","volume":"61","author":"Zhang","year":"2023","journal-title":"Eur Respir J"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:09:01Z","timestamp":1762031341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323008810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1569199323008810"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pediatric cystic fibrosis arthropathy case who responded to Elexacaftor\/Tezacaftor\/Ivacaftor therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}